Amoxyclav 625 contains a combination of amoxicillin, a penicillin-class antibiotic, and clavulanic acid, a beta-lactamase inhibitor that helps protect amoxicillin from bacterial resistance mechanisms.

This combination expands the spectrum of activity against many bacteria that may not respond to amoxicillin alone. Amoxyclav is widely used in the treatment of upper and lower respiratory tract infections, sinusitis, otitis media, dental infections, skin and soft tissue infections, and selected urinary tract infections.

The addition of clavulanic acid improves effectiveness against beta-lactamase-producing organisms, making it a commonly prescribed antibiotic in both outpatient and hospital settings.

Treatment decisions, dosage schedules, and duration of therapy should always be determined by a qualified healthcare professional.